Home
/ Ablynx
/ Competitors

Ablynx Competitors and Similar CompaniesClear all

Ablynx's competitors and similar companies include ImmunoGen and CytomX Therapeutics.

	Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.	ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.	CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Founding Date	Founding Date 2001	Founding Date 1981	Founding Date 2008
Type	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Gent, BE HQ	Locations Waltham, US HQ	Locations South San Francisco, US HQ
Employees	Employees 1252% decrease	Employees 277161% increase	Employees 15815% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 8.7 b	Valuation ($) 78 m
Financial
Revenue (est.)	Revenue (est.) €85.2m (FY, 2016)	Revenue (est.) $108.8m (FY, 2022)	Revenue (est.) $76.2m (FY, 2025)
Net income	Net income (€1.1m) (FY, 2016)	Net income ($222.9m) (FY, 2022)	Net income ($17.4m) (FY, 2025)
Operating ⚠
Patents (Foreign)	Patents (Foreign) 180 (Q2, 2017)	Patents (Foreign) N/A	Patents (Foreign) 4 (FY, 2016)
Patents (US)	Patents (US) 50 (Q2, 2017)	Patents (US) N/A	Patents (US) 13 (FY, 2016)
Funding
Total funding raised	Total funding raised $ 498.8m	Total funding raised $ 56m	Total funding raised $ 132.4m